BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37250786)

  • 1. Cathepsin K promotes the proliferation of hepatocellular carcinoma cells through induction of SIAH1 ubiquitination and degradation.
    Zhang C; Liu Z; Wang X; Zhang B; Cui L; Hu Q; Hu B; Cao K; Shan W; Shi H; Wang R
    iScience; 2023 Jun; 26(6):106852. PubMed ID: 37250786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin ligase NEDD4 promotes the proliferation of hepatocellular carcinoma cells through targeting PCDH17 protein for ubiquitination and degradation.
    Liu Z; Hu Q; Hu B; Cao K; Xu T; Hou T; Cao T; Wang R; Shi H; Zhang B
    J Biol Chem; 2024 Jan; 300(1):105593. PubMed ID: 38145746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteome-wide identification and functional analysis of ubiquitinated proteins in Hepa1-6 cells by knockdown of E3 ubiquitin ligase SIAH1.
    Hu X; Zhu Z; Liu K; Liu J; Li J; Wang Z
    Transl Cancer Res; 2024 Jan; 13(1):102-111. PubMed ID: 38410210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Siah1 promotes the proliferation of NSCLC cells through ubiquitinating and stabilizing Notch1.
    Liu Y; Li Q; Geng L; Zhou X; Zhou X; Dong Y; Zhang Y
    Exp Cell Res; 2022 Oct; 419(1):113305. PubMed ID: 35961388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of miR-299-5p inhibits the progression of hepatocellular carcinoma by targeting SIAH1.
    Jiang X; Shen X
    Bull Cancer; 2018 Oct; 105(10):873-883. PubMed ID: 30266288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E3 ubiquitin ligase Siah1 aggravates NAFLD through Scp2 ubiquitination.
    Zhu Z; Hu X; Liu K; Li J; Fan K; Wang H; Wang L; He L; Ma Y; Guan R; Wang Z
    Int Immunopharmacol; 2023 Nov; 124(Pt A):110897. PubMed ID: 37696143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NEDD4 Induces K48-Linked Degradative Ubiquitination of Hepatitis B Virus X Protein and Inhibits HBV-Associated HCC Progression.
    Wan T; Lei Z; Tu B; Wang T; Wang J; Huang F
    Front Oncol; 2021; 11():625169. PubMed ID: 33767993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of Siah1 promotes colorectal cancer cell proliferation and migration by regulating AKT and YAP ubiquitylation and proteasome degradation.
    Xiao Z; Wei Z; Deng D; Zheng Z; Zhao Y; Jiang S; Zhang D; Zhang LJ; Fan M; Chen S; Wang S; Ding Y; Ye Y; Jiao H
    Cancer Cell Int; 2020; 20():50. PubMed ID: 32082080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NEDD4 promotes cell growth and migration via PTEN/PI3K/AKT signaling in hepatocellular carcinoma.
    Huang ZJ; Zhu JJ; Yang XY; Biskup E
    Oncol Lett; 2017 Sep; 14(3):2649-2656. PubMed ID: 28928809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin K activity controls cachexia-induced muscle atrophy via the modulation of IRS1 ubiquitination.
    Meng X; Huang Z; Inoue A; Wang H; Wan Y; Yue X; Xu S; Jin X; Shi GP; Kuzuya M; Cheng XW
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1197-1209. PubMed ID: 35098692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIAH1 ubiquitin ligase mediates ubiquitination and degradation of Akt3 in neural development.
    Ko HR; Jin EJ; Lee SB; Kim CK; Yun T; Cho SW; Park KW; Ahn JY
    J Biol Chem; 2019 Oct; 294(42):15435-15445. PubMed ID: 31471318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FRK inhibits glioblastoma progression via phosphorylating YAP and inducing its ubiquitylation and degradation by Siah1.
    Wang Y; Wang K; Fu J; Zhang Y; Mao Y; Wang X; Wang X; Yu R; Zhou X
    Neuro Oncol; 2022 Dec; 24(12):2107-2120. PubMed ID: 35723276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA SNHG1 promotes α-synuclein aggregation and toxicity by targeting miR-15b-5p to activate SIAH1 in human neuroblastoma SH-SY5Y cells.
    Chen Y; Lian YJ; Ma YQ; Wu CJ; Zheng YK; Xie NC
    Neurotoxicology; 2018 Sep; 68():212-221. PubMed ID: 29217406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CacyBP/SIP inhibits the migration and invasion behaviors of glioblastoma cells through activating Siah1 mediated ubiquitination and degradation of cytoplasmic p27.
    Yan S; Li A; Liu Y
    Cell Biol Int; 2018 Feb; 42(2):216-226. PubMed ID: 29024247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIAH1-mediated RPS3 ubiquitination contributes to chemosensitivity in epithelial ovarian cancer.
    Chen L; Gao W; Sha C; Yang M; Lin L; Li T; Wei H; Chen Q; Xing J; Zhang M; Zhao S; Xu W; Li Y; Zhu X
    Aging (Albany NY); 2022 Aug; 14(15):6202-6226. PubMed ID: 35951361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatase and tensin homolog deleted on chromosome 10 degradation induced by NEDD4 promotes acquired erlotinib resistance in non-small-cell lung cancer.
    Sun H; Ma H; Wang J; Xia L; Zhu G; Wang Z; Sun J; Chen Z
    Tumour Biol; 2017 Jul; 39(7):1010428317709639. PubMed ID: 28714370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deubiquitinase USP39 and E3 ligase TRIM26 balance the level of ZEB1 ubiquitination and thereby determine the progression of hepatocellular carcinoma.
    Li X; Yuan J; Song C; Lei Y; Xu J; Zhang G; Wang W; Song G
    Cell Death Differ; 2021 Aug; 28(8):2315-2332. PubMed ID: 33649471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of SIAH1 in SH-SY5Y affects α-synuclein degradation pathway.
    Xu J; Zhang XZ; Zhang YJ; Li XM; Cai ZL; Li XM
    Int J Clin Exp Pathol; 2015; 8(10):12885-92. PubMed ID: 26722480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UBE2O promotes hepatocellular carcinoma cell proliferation and invasion by regulating the AMPKα2/mTOR pathway.
    Shi Z; Liu R; Lu Q; Zeng Z; Liu Y; Zhao J; Liu X; Li L; Huang H; Yao Y; Huang D; Xu Q
    Int J Med Sci; 2021; 18(16):3749-3758. PubMed ID: 34790050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insufficient ablation induces E3-ligase Nedd4 to promote hepatocellular carcinoma progression by tuning TGF-β signaling.
    Li K; Niu Y; Yuan Y; Qiu J; Shi Y; Zhong C; Qiu Z; Li K; Lin Z; Huang Z; Zhang C; Zuo D; He W; Yuan Y; Li B
    Oncogene; 2022 Jun; 41(23):3197-3209. PubMed ID: 35501461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.